Safety, Tolerability and Pharmacokinetics and Effect on Inflammation of Oral BI 1026706 in Patients With COPD
Clinical trial NCT02642614 · COMPLETED
Trial details
- NCT number
- NCT02642614
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2016-06-14
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.